Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marjan Gharagozloo

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Journal of Neuroimmunology|July 13, 2013
Biased Treg/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptomsAzam Jamshidian, Vahid Shaygannejad, Abbasali Pourazar, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|March 25, 2010
The expression of Th1- and Th2-related chemokine receptors in women with recurrent miscarriage: the impact of lymphocyte immunotherapyNasim Kheshtchin, Marjan Gharagozloo, Alireza Andalib, et al.
European Journal of Haematology|January 3, 2013
A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamineBehjat Moayedi, Marjan Gharagozloo, Nafiseh Esmaeil, et al.
Cells|August 29, 2018
The Dual Immunoregulatory function of <i>Nlrp12</i> in T Cell-Mediated Immune Response: Lessons from Experimental Autoimmune EncephalomyelitisMarjan Gharagozloo, Shaimaa Mahmoud, Camille Simard, et al.
Basic & Clinical Pharmacology & Toxicology|May 25, 2013
Immunosuppressive effect of silymarin on mitogen-activated protein kinase signalling pathway: the impact on T cell proliferation and cytokine productionMarjan Gharagozloo, Shirin Jafari, Nafiseh Esmaeil, et al.
Frontiers in Immunology|February 7, 2018
NLR-Dependent Regulation of Inflammation in Multiple SclerosisMarjan Gharagozloo, Katsiaryna V Gris, Tara Mahvelati, et al.
Advanced Biomedical Research|September 15, 2017
Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's LymphomaShirin Kouhpayeh, Alireza Andalib, Marjan Gharagozloo, et al.
Fundamental & Clinical Pharmacology|May 21, 2009
Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trialMarjan Gharagozloo, Behjat Moayedi, Maryam Zakerinia, et al.
International Immunopharmacology|June 20, 2006
Effects of silymarin on the proliferation and glutathione levels of peripheral blood mononuclear cells from beta-thalassemia major patientsFariba Alidoost, Marjan Gharagozloo, Bahram Bagherpour, et al.
Journal of Neuroimmunology|April 8, 2022
Retinal pathology in spontaneous opticospinal experimental autoimmune encephalitis miceJing Jin, Mark Shneyderman, Matthew D Smith, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Journal of Neuroimmunology|July 13, 2013
Biased Treg/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptomsAzam Jamshidian, Vahid Shaygannejad, Abbasali Pourazar, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|March 25, 2010
The expression of Th1- and Th2-related chemokine receptors in women with recurrent miscarriage: the impact of lymphocyte immunotherapyNasim Kheshtchin, Marjan Gharagozloo, Alireza Andalib, et al.
European Journal of Haematology|January 3, 2013
A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamineBehjat Moayedi, Marjan Gharagozloo, Nafiseh Esmaeil, et al.
Cells|August 29, 2018
The Dual Immunoregulatory function of <i>Nlrp12</i> in T Cell-Mediated Immune Response: Lessons from Experimental Autoimmune EncephalomyelitisMarjan Gharagozloo, Shaimaa Mahmoud, Camille Simard, et al.
Basic & Clinical Pharmacology & Toxicology|May 25, 2013
Immunosuppressive effect of silymarin on mitogen-activated protein kinase signalling pathway: the impact on T cell proliferation and cytokine productionMarjan Gharagozloo, Shirin Jafari, Nafiseh Esmaeil, et al.
Frontiers in Immunology|February 7, 2018
NLR-Dependent Regulation of Inflammation in Multiple SclerosisMarjan Gharagozloo, Katsiaryna V Gris, Tara Mahvelati, et al.
Advanced Biomedical Research|September 15, 2017
Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's LymphomaShirin Kouhpayeh, Alireza Andalib, Marjan Gharagozloo, et al.
Fundamental & Clinical Pharmacology|May 21, 2009
Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trialMarjan Gharagozloo, Behjat Moayedi, Maryam Zakerinia, et al.
International Immunopharmacology|June 20, 2006
Effects of silymarin on the proliferation and glutathione levels of peripheral blood mononuclear cells from beta-thalassemia major patientsFariba Alidoost, Marjan Gharagozloo, Bahram Bagherpour, et al.
Journal of Neuroimmunology|April 8, 2022
Retinal pathology in spontaneous opticospinal experimental autoimmune encephalitis miceJing Jin, Mark Shneyderman, Matthew D Smith, et al.
Pageof 7